Emergent BioSolutions Ownership | Who Owns Emergent BioSolutions?


OverviewForecastRevenueFinancialsChartTranscripts

Emergent BioSolutions Ownership Summary


Emergent BioSolutions is owned by 88.22% institutional investors, 4.26% insiders, and 7.52% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 9.09% of EBS shares. Avantis US Small Cap Value ETF is the top mutual fund, with 5.00% of its assets in Emergent BioSolutions shares.

EBS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEmergent BioSolutions88.22%4.26%7.52%
SectorHealthcare Stocks 244.59%12.11%-156.70%
IndustrySpecialty & Generic Drug Manufacturers Stocks37.12%13.99%48.89%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de4.72M9.09%$39.53M
Blackrock3.84M7.36%$26.18M
Vanguard group3.55M6.68%$43.93M
Dimensional fund advisors lp3.08M5.93%$25.78M
State street2.93M5.64%$24.56M
American century companies2.77M5.34%$23.22M
Vanguard capital management2.20M4.24%$18.43M
Lsv asset management1.70M3.27%$14.21M
Acadian asset management1.34M2.59%$11.26M
Geode capital management1.34M2.58%$11.21M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Oak hill advisors lp1.11M1.33%$9.33M
Values first advisors4.18K1.21%$2.53M
Kent lake capital300.00K0.92%$2.05M
Prosight management, lp459.95K0.66%$3.85M
Prescott group capital management772.77K0.56%$6.48M
Soviero asset management, lp100.00K0.35%$838.00K
Globeflex capital l p241.30K0.26%$2.02M
Morse asset management183.33K0.25%$1.54M
Palisade capital management, lp515.06K0.19%$4.32M
Ancora advisors1.07M0.17%$8.95M

Top Buyers

HolderShares% AssetsChange
Sixth street partners management company1.20M0.00%1.20M
Lsv asset management1.70M0.03%799.15K
Ancora advisors1.07M0.17%658.60K
Millennium management1.07M0.00%540.18K
Russell investments group859.48K0.01%523.58K

Top Sellers

HolderShares% AssetsChange
Blackrock3.84M0.00%-3.22M
Avidity partners management lp---1.91M
Palisade capital management, lp515.06K0.19%-686.26K
Marshall wace, llp---577.73K
Carronade capital management, lp---550.60K

New Positions

HolderShares% AssetsChangeValue
Sixth street partners management company1.20M0.00%1.20M$10.06M
Whitebox advisors500.00K0.10%500.00K$3.41M
Panagora asset management329.06K0.01%329.06K$2.76M
Kent lake capital300.00K0.92%300.00K$2.05M
Macquarie management122.70K0.00%122.70K$1.03M

Sold Out

HolderChange
National bank of canada /fi/-1.00
Flagship harbor advisors-2.00
Frazier financial advisors-2.00
Walleye capital-4.00
Federation des caisses desjardins du quebec-4.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20262002.04%45,788,4285.42%881.26%104-4.59%6219.23%
Mar 31, 2026187-2.09%42,805,974-1.39%801.20%1042.97%50-3.85%
Dec 31, 202546-74.73%6,057,668-85.48%110.19%26-69.41%7-87.27%
Sep 30, 202568-61.14%10,191,249-74.33%180.35%28-72.28%19-47.22%
Jun 30, 20251723.61%39,625,9449.49%731.65%10012.36%35-12.50%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Avantis US Small Cap Value ETF2.56M5.00%5.53K
State Street® SPDR® S&P® Biotech ETF1.68M3.28%3.86K
Vanguard MStar Total Stk Mkt Idx Invest1.55M3.03%-
Vanguard Morn Total Stk Mkt Idx Investor1.55M3.01%-54.50K
Vanguard Total Stock Mkt Idx Inv1.55M3.01%-54.50K
Vanguard US Total Market Shares ETF1.64M3.01%-
iShares Russell 2000 ETF1.35M2.64%-24.00K
SPDR® S&P Biotech ETF949.18K1.78%2.12K
Invesco FTSE RAFI US 1500 Small-Mid ETF917.91K1.69%-
Palisade Small Cap Core Equity872.78K1.68%11.84K

Recent Insider Transactions


DateNameRoleActivityValue
Jul 01, 2026Williams Paul Anthony SVP, Products BusinessSell$25.20K
May 01, 2026Dayal Sujata Tyagi-Sell$8.76K
May 01, 2026Dayal Sujata Tyagi-Sell$106.85K
May 01, 2026DeGolyer Donald W-Sell$121.45K
May 01, 2026DeGolyer Donald W-Sell$8.55K

Insider Transactions Trends


DateBuySell
2026 Q3-1
2026 Q2-8
2026 Q1--
2025 Q4-5
2025 Q3-2

EBS Ownership FAQ


Who Owns Emergent BioSolutions?

Emergent BioSolutions shareholders are primarily institutional investors at 88.22%, followed by 4.26% insiders and 7.52% retail investors. The average institutional ownership in Emergent BioSolutions's industry, Specialty & Generic Drug Manufacturers Stocks, is 37.12%, which Emergent BioSolutions exceeds.

Who owns the most shares of Emergent BioSolutions?

Emergent BioSolutions’s largest shareholders are Blackrock funding, inc. /de (4.72M shares, 9.09%), Blackrock (3.84M shares, 7.36%), and Vanguard group (3.55M shares, 6.68%). Together, they hold 23.12% of Emergent BioSolutions’s total shares outstanding.

Does Blackrock own Emergent BioSolutions?

Yes, BlackRock owns 7.36% of Emergent BioSolutions, totaling 3.84M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 26.18M$. In the last quarter, BlackRock decreased its holdings by -3.221M shares, a -45.62% change.

Who is Emergent BioSolutions’s biggest shareholder by percentage of total assets invested?

Oak hill advisors lp is Emergent BioSolutions’s biggest shareholder by percentage of total assets invested, with 1.33% of its assets in 1.11M Emergent BioSolutions shares, valued at 9.33M$.

Who is the top mutual fund holder of Emergent BioSolutions shares?

Avantis US Small Cap Value ETF is the top mutual fund holder of Emergent BioSolutions shares, with 5.00% of its total shares outstanding invested in 2.56M Emergent BioSolutions shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools